Found: 5
Select item for more details and to access through your institution.
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 775, doi. 10.1007/s10549-018-05127-2
- By:
- Publication type:
- Article
Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature.
- Published in:
- Familial Cancer, 2023, v. 22, n. 3, p. 283, doi. 10.1007/s10689-023-00331-6
- By:
- Publication type:
- Article
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-63759-1
- By:
- Publication type:
- Article
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00089
- By:
- Publication type:
- Article